The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
IMI
IMI is a medical device manufacturer delivering high-quality, American made, single-use and sterile devices for pharmaceutical compounding. For 50 years, IMI has worked closely with pharmacists and compounding professionals to create innovative devices that meet very specialized needs. Throughout this time, IMI has established long-standing partnerships with some of the biggest names in healthcare. Through these partnerships and directly, IMI is delivering the high-quality and high-value products that pharmacy operations demand. All IMI products are manufactured in the USA under the strictest quality standards at their FDA licensed, ISO 13485 certified facility.
At the core of IMI’s product line, you will find our unique tamper-evident technologies. These products offer an active deterrent to potential drug diversion and misuse. Our tamper-evident products are an essential component of a health system’s total drug security program.
We believe that our customers and the patients they serve deserve only the highest level of quality and security. We are committed to our customer’s satisfaction. When you partner with us, you not only receive high-quality devices from the industry leader in Tamper Evident Cap Technology, you also receive a dedicated team of support professionals available to you when you need them. Our mission is to build long-lasting relationships with pharmaceutical and compounding professionals to continuously advance our devices to serve the healthcare industry.